PROM1 and glioblastoma: Notably, the data of GJIC formation between F3.CD-TK and G55 cells expressing CD133, a marker of CSCs [33,34,35], indicated that gap junction-mediated intercellularly transport of GCV-TP and ionized 5FU may directly damage CSCs, a crucial target for GBM management [35].